Solesence, Inc. Common Stock cash flow to debt ratio of -35.23% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Solesence, Inc. Common Stock's free cash flow has decreased 313.99% from $-2.59M last year to $-10.71M, signaling decreasing performance

Solesence, Inc. Common Stock's debt to equity ratio is 1.31, which means that the company's assets are unhealthy financed, signaling financial risk.

Solesence, Inc. Common Stock's debt has increased relative to shareholder equity from 1.02 last year to 1.31 today, signaling weakened financials

Solesence, Inc. Common Stock has a net debt to EBITDA ratio of 6.24x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk

Solesence, Inc. Common Stock's interest coverage ratio is 0.80, which means that the company struggles to meet interest obligations, signaling financial risk.

Solesence, Inc. Common Stock's profit margin has decreased (80.68%) in the last year from 8.09% to 1.56%, signaling decreasing performance

Solesence, Inc. Common Stock's short-term assets of $28.78M exceed its short-term liabilities of $13.93M

Solesence, Inc. Common Stock's return on assets of 1.98% is lower than the 5.00% threshold, indicating inefficient asset utilization

Solesence, Inc. Common Stock's return on equity of 5.39%, is lower than 15.00%, indicating bad performance

Solesence, Inc. Common Stock's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Solesence, Inc. Common Stock had positive net income in 3 out of 5 years, indicating stable and consistent earnings

Solesence, Inc. Common Stock has negative free cash flow, indicating the company is burning cash rather than generating it

Solesence, Inc. Common Stock has negative free cash flow, indicating cash burn

Solesence, Inc. Common Stock's yearly earnings has decreased 57.73% since last year from $4.24M to $1.79M, signaling decreasing performance

Solesence, Inc. Common Stock's yearly revenue has increased 18.56% since last year from $52.35M to $62.06M, signaling increasing performance

ROIC 1.91% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Solesence, Inc. Common Stock's 3-year revenue CAGR of 18.48% is positive, indicating growing revenue over the past 3 years

Solesence, Inc. Common Stock had revenue growth in 3 out of 5 years, indicating consistent revenue performance

Solesence, Inc. Common Stock had positive ROE in 3 out of 5 years, indicating consistent and reliable returns on equity

Solesence, Inc. Common Stock has insufficient data to evaluate this check.

Solesence, Inc. Common Stock has an earnings yield of 1.30%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Solesence, Inc. Common Stock is overvalued relative to its fair value price of 0.04 based on EBITDA multiple model

Solesence, Inc. Common Stock has an EV/EBITDA ratio of 25.95x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings

Solesence, Inc. Common Stock has insufficient data to evaluate this check.

Solesence, Inc. Common Stock has insufficient diluted EPS history to calculate the PEG ratio.

Solesence, Inc. Common Stock has a price-to-book ratio of 4.29x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Solesence, Inc. Common Stock has a price-to-sales ratio of 1.20x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue